Effect of probiotics on human blood urea levels in patients with chronic renal failure;Efecto de lactobacillus casei shirota sobre concentraciones de urea en la enfermedad renal crónica

Nutricion Hospitalaria

Volumn 29, Issue 3, 2014, Pages 582-590

  Alatriste, Paola Vanessa Miranda ^a,b   Arronte, Rocío Urbina ^b   Espinosa, Cristóbal Obet Gómez ^b   Cuevas, María de los Ángeles Espinosa ^a,b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Dose; Lactobacillus casei Shirota; Probiotics; Ureas; Uremic toxins

Indexed keywords

PROBIOTIC AGENT; UREA;

ADULT; BLOOD; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROBIOTICS; UREA;

EID: 84896870046     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/NH.2014.29.3.7179     Document Type: Article

References (35)

1. De las Cagigas Reig AL, Anesto JB. Prebióticos y probióticos, una relación beneficiosa. Revista Cubana Aliment Nutr 2002; 16: 63-8.
2. Chow J. Probiotics and prebiotics: A brief overview. J Ren Nutr 2002; 12 (2): 76-86.
3. Castro L, De Rovet C. Probiotics: clinical benefits. Colomb Méd 2006; 37: 308-14.
4. Reid G, Jass J, Seb ulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003; 16 (4): 658-72.
5. Usha V, Natarajan R. Probiotics, Prebiotics, and Synbiotics: Gut and Beyond, Gastroenterology Research and Practice, vol. 2012, Article ID 872716, 16 pages, 2012.
6. Guarner Francisco. Enteric Flora in Health and Disease. Digestión 2006; 73 (Suppl. 1): 5-12.
7. Miñana Vitoria. Probióticos, prebióticos y simbióticos. Pediatr Integral 2007; 11: 425-33.
8. Senok AC, Ismaeel AY, Botta GA. Probiotics: facts and myths. Clin Microbiol Infect 2005; 11: 958-66.
9. Stanton C, Gardiner G, Meehan H, Collins K, Fitzgerald G, LynchB. Marketpotential for probiotics. Am J Clin Nutr 2001; 73 (Suppl.): 476S-83S.
10. Roberfroid Marcel, Prebiotics and probiotics: are they functional foods? Am J Clin Nutr 2000; 71 (Suppl.): 168S-7S.
11. Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between 1988 and 1998. Am J Clin Nutr 2000; 71: 405-11.
12. Gill HS, Guarner F. Probiotics and human health: a clinical perspective. Postgrad Med J 2004; 80: 516-26.
13. Santosa S, Farnworth E, Jones M. Probiotics and their potential health claims. Nutrition Reviews 2006; 64: 265-74.
14. Walker A, Goulet O, Morelli L, Antoine JM. Progress in the science of probiotics: from cellular microbiology and applied immunology to clinical nutrition. Eur J Nutr 2006; 45 (Suppl. 1): 1-18.
15. Parvez S, Malik KA, Kang A, Kim HY. Probiotics and their fermented food products are beneficial for health. Journal of Applied Microbiology 2006; 100: 1171-85.
16. Mexican Official Norm NO M-092-SSA1-1994. Services and goods. Counting method for aerobic bacteria in substrates. Federation Official Diary 1995.
17. Kang JY. The gastrointes tinal tract in uremia. Dig Dis Sci 1993; 38 (2): 257-68.
18. Simenhoff ML, Dunn SR. A ltered gut flora in uremia. Journal of Renal Nutrition 1996; 6: 68-74.
19. Taki K, Takayama F, Niwa T. Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients. J Renal Nutr 2005; 15: 77-80.
20. Nosratola, CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens 2012; 21 (6): 587-92.
21. Nakabayashi Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant 2011; 26: 1094-8.
22. Wijnkoop LI, Sanders ME, Cabana M, Caglar E, Corthier G, Reyes N et al. Probiotic and prebiotic influence beyond the intestinal tract. Nutrition Reviews 2007; 65: 469-89.
23. Chow KM, Liu ZC, Prakash S, Chang TM. Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal. Artif Cells Blood Substit Immobil Biotechnol 2003; 31 (4): 425-34.
24. Simenhoff ML, Dunn SR, Zollner GP et al. Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab 1996; 22: 92-6.
25. Dunn SR, Simenhoff ML, Ahmed KE, et al. Effect of oral administration of freeze-dried Lactobacillus acidophilus on small bowel bacterial overgrowth in patients with end stage kidney disease: reducing uremic toxins and improving nutrition. International dairy journal 1998; 8: 545-53.
26. Takayama F, Taki K, Niwa T. Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. Am J Kidney Dis 2003; 41 (3 Suppl. 1): S142-5.
27. Sako ST. Probiotics and Health Claims. In: Kneifel W, Salminen S, editors. Oxford UK: Wiley-Blackwell; 2011, pp. 18-36.
28. Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T. Inhibitory effect of oral administration of Lactobacillus casei on 3-methylcholanthrene-induced carcinogenesis in mice. Med Microbiol Immunol 1999; 188 (3): 111-6.
29. Matsuzaki T. Immunomodul ation by treatment with Lactobacillus casei strain Shirota. Int J Food Microbiol 1998; 41 (2): 133-40.
30. Tuomola EM, Ouwehand AC, Salminen SJ. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol Med Microbiol 1999; 26 (2): 137-42.
31. Torre A, Vargas F. Maste r's Thesis. Effects of short-term administration of a lactobacillus casei drink (yakult) on the intestinal flora, intestinal permeability, endotoxins, cytokines, ammonium and nitric oxide in patients with chronic renal failure. National Autonomous University of Mexico. México D.F. 2004.
32. Kato I, Endo-Tanaka K, Yokokura T. Suppressive effects of the oral administration of Lactobacillus casei on type II collagen-induced arthritis in DBA/1 mice. Life Sci 1998; 63 (8): 635-44.
33. Kikuchi-Hayakawa H, Shibahara-Sone H, Osada K, Onodera-Masuoka N, Ishikawa F, Watanuki M. Lower plasma triglyceride level in Syrian hamsters fed on skim milk fermented with Lactobacillus casei strain Shirota. Biosci Biotechnol Biochem 2000; 64 (3): 466-75.
34. Matsuzaki T, Chin J. Modu lating immune responses with probiotic bacteria. Immunol Cell Biol 2000; 78 (1): 67-73.
35. Garza GC, Miranda MP, Espinosa EA. Benefits of probiotics on renal disease: new applications. Nutrición Clínica 2008; 11: 24-34.